TRILLIUM THERAPEUTICS INC. Stock-Based Compensation
TRILLIUM THERAPEUTICS INC. reported Stock-Based Compensation of $12.34 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2021-09-30 was $6.39M, a 10.94% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2021-06-30 was $2.92M, a 82.54% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2021-03-31 was $3.02M, a 73.06% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $1.30M.
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2020 was $36.45M, a 692.76% increase from fiscal 2019.
- TRILLIUM THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2019 was $4.60M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $9.31M derived: sum of 2 quarters · filed 2021-11-12 | $12.34M 10-Q · filed 2021-11-12 | $13.64M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $5.95M 10-Q · filed 2021-08-13 | $7.25M derived: sum of 3 quarters · filed 2021-08-13 | $14.42M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $3.02M 10-Q · filed 2021-05-07 | $4.32M derived: sum of 2 quarters · filed 2021-05-07 | $11.50M derived: sum of 3 quarters · filed 2021-11-12 | $28.25M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $8.47M derived: sum of 2 quarters · filed 2021-11-12 | $25.23M derived: sum of 3 quarters · filed 2021-11-12 | $36.45M 10-K · filed 2021-03-18 |
| 2020-09-30 | $7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $23.93M derived: sum of 2 quarters · filed 2021-11-12 | $35.15M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $16.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $27.98M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $11.22M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $4.60M 10-K · filed 2021-03-18 |